DIVIDEND POLICY

S u b mi t t e d b y
S r i dhar ( 68)
Ni k hi l ( 103)
s uma s al omi ( 87)
adar s h( 61)
r ahi l ( 102)

3 / 1 8 / 2 0 1 4

Submitted to
S.V Ramana rao
REGARDING DETAILS OF
5 PHARMA COMPANY
DIVIDEND POLICY



DR. REDDYS LABORATORIES:

Market value: 2775.90
Column1 mar'13 mar'12 mar'11 mar'10 mar'09
Earnings Per Share 74.51 53.81 52.78 50.11 33.29
Book Value 458.29 396.19 355.69 350.3 312.17
Face Value 5 5 5 5 5




Dividend:


Announcement Dat Effective Date Dividend Type Dividend (%) Remarks
14/5/2013 12/7/2013 Final 300 Rs.15.0000 per share(300%)Final Dividend
11/5/2012 28/6/2012 Final 275 Rs. 13.75 per share (275%) Final Dividend
13/5/2011 30/6/2011 Final 225 Rs.11.25 per share(225%)Final Dividend
6/5/2010 2/7/2010 Final 225 -
18/5/2009 3/7/2009 Final 125 -
20/5/2008 4/7/2008 Final 75 AGM

Dividend Summary
For the year ending March 2013, Dr Reddys Laboratories has declared an equity dividend of 300.00%
amounting to Rs 15 per share. At the current share price of Rs 2725.30 this results in a dividend yield of
0.55%.

The company has a good dividend track report and has consistently declared dividends for the last 5
years.


Cipla:

Market value: 385.85

Column1 mar'13 mar'12 mar'11 mar'10 mar'09
Face Value 2 2 2 2 2
Earnings Per Share 18.77 14 11.96 13.47 9.99
Book Value 110.47 94.04 82.36 73.55 55.86

Dividend:
Announcement Date Effective
Date
Dividend
Type
Dividend
(%)
Remarks
29/5/2013 6/8/2013 Final 100
Rs.2.0000 per
share(100%)Dividend
7/6/2012 1/8/2012 Final 100 -
29/6/2011 9/8/2011 Final 100 -
25/8/2010 3/9/2010 Interim 40 Special Interim Dividend
15/6/2010 23/7/2010 Final 100 -
15/7/2009 10/8/2009 Final 100 -
18/7/2008 12/8/2008 Final 100 AGM

Dividend Summary
For the year ending March 2013, Cipla has declared an equity
dividend of 100.00% amounting to Rs 2 per share. At the current
share price of Rs 386.50 this results in a dividend yield of 0.52%.

The company has a good dividend track report and has
consistently declared dividends for the last 5 years.








Ranbaxy Laboratories:
Market value: 343.65
Column1 mar'13 mar'12 mar'11 mar'10 mar'09
Face Value 5 5 5 5 5
Earnings Per Share -3.84 -72.32 27.28 13.61 -24.85
Book Value 45.42 45.6 121.74 94.16 84.24

Dividend:
Announcement Date Effective
Date
Dividend
Type
Dividend
(%)
Remarks
22/2/2011 28/4/2011 Final 40 -
28/3/2008 21/5/2008 Final 120 -
18/10/2007 1/11/2007 Interim 50 -
16/3/2007 4/4/2007 Interim 120 Second Interim Dividend
19/10/2006 2/11/2006 Interim 50 -
19/4/2006 15/6/2006 Final 120 AGM (of par value of Rs.5 each)

Ranbaxy Laboratories had last declared a dividend of 40.00% for the year
ending December 2010.
Lupin:
year date Book
value
Dividend
type
Dividend
%
Face vale Dividend per
share
EPS
2013 8/5/13 108.30 final 200% 2 4.00 28.16
2012 10/5/12 83.61 final 160% 2 3.20 18.11
2011 12/5/11 70.66 final 150% 10 3.00 18.15
2010 5/5/10 284.51 final 135% 10 13.50 72.96
2009 13/5/09 166.06 final 125% 10 12.50 50.35
Dividend Summary
For the year ending March 2013, Lupin has declared an equity dividend
of 200.00% amounting to Rs 4 per share. At the current share price of
Rs 944.55 these results in a dividend yield of 0.42%.

The company has a good dividend track report and has consistently
declared dividends for the last 5 years

Abbott:
year Date Book value Dividend
type
Dividend
%
Face
vale
Dividend
per share
EPS
2013 16/4/13 304.41 Final 170% 10 17.00 68.10
2012
4/6/12 256.08 Final 170% 10 17.00 56.66
2011 19/4/11 223.31 Final 170% 10 17.00 44.56
2010 3/3/10 198.58 Final 170% 10 17.00 56.96
2009 9/3/09 161.79 Final

170% 10 14.00 45.24

Dividend Summary
For the year ending December 2012, Abbott India has declared
an equity dividend of 170.00% amounting to Rs 17 per share. At
the current share price of Rs 1664.05 these results in a dividend
yield of 1.02%.

Abbott India had last declared a dividend of 170.00% for the
year ending December 2012